153 related articles for article (PubMed ID: 33931899)
1. Multicentric dermatofibrosarcoma protuberans in a child with severe combined immunodeficiency due to adenosine deaminase deficiency.
Wahjudi TD; Kutzner H; Bleeke M; Hoeger PH
Pediatr Dermatol; 2021 Jul; 38(4):875-878. PubMed ID: 33931899
[TBL] [Abstract][Full Text] [Related]
2. Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency.
Kesserwan C; Sokolic R; Cowen EW; Garabedian E; Heselmeyer-Haddad K; Lee CC; Pittaluga S; Ortiz C; Baird K; Lopez-Terrada D; Bridge J; Wayne AS; Candotti F
J Allergy Clin Immunol; 2012 Mar; 129(3):762-769.e1. PubMed ID: 22153773
[TBL] [Abstract][Full Text] [Related]
3. Medallion-Like Dermal Dendrocytic Hamartoma, Dermatofibrosarcoma Protuberans, and Adenosine Deaminase-Deficient Severe Combined Immunodeficiency.
Cowen EW; Pichard DC; Garabedian E; Miettinen M
Pediatr Dermatol; 2016 May; 33(3):359-60. PubMed ID: 27176810
[No Abstract] [Full Text] [Related]
4. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ
J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787
[TBL] [Abstract][Full Text] [Related]
5. Atypical Hemolytic Uremic Syndrome (aHUS) and Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID)-Two Diseases That Exacerbate Each Other: Case Report.
Bogdał A; Badeński A; Pac M; Wójcicka A; Badeńska M; Didyk A; Trembecka-Dubel E; Dąbrowska-Leonik N; Walaszczyk M; Matysiak N; Morawiec-Knysak A; Szczepański T; Szczepańska M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502390
[TBL] [Abstract][Full Text] [Related]
6. How We Manage Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA SCID).
Kohn DB; Gaspar HB
J Clin Immunol; 2017 May; 37(4):351-356. PubMed ID: 28194615
[TBL] [Abstract][Full Text] [Related]
7. Maternal T-cell engraftment impedes with diagnosis of a SCID-ADA patient.
Lanfranchi A; Lougaris V; Notarangelo LD; Soncini E; Comini M; Beghin A; Bolda F; Montanelli A; Imberti L; Porta F
Clin Immunol; 2018 Aug; 193():118-120. PubMed ID: 29355610
[TBL] [Abstract][Full Text] [Related]
8. Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.
Sokolic R; Maric I; Kesserwan C; Garabedian E; Hanson IC; Dodds M; Buckley R; Issekutz AC; Kamani N; Shaw K; Tan B; Bali P; Hershfield MS; Kohn DB; Wayne AS; Candotti F
Blood; 2011 Sep; 118(10):2688-94. PubMed ID: 21725047
[TBL] [Abstract][Full Text] [Related]
9. Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome.
Nikolajeva O; Worth A; Hague R; Martinez-Alier N; Smart J; Adams S; Davies EG; Gaspar HB
J Clin Immunol; 2015 May; 35(4):366-72. PubMed ID: 25875700
[TBL] [Abstract][Full Text] [Related]
10. Non-infectious lung disease in patients with adenosine deaminase deficient severe combined immunodeficiency.
Booth C; Algar VE; Xu-Bayford J; Fairbanks L; Owens C; Gaspar HB
J Clin Immunol; 2012 Jun; 32(3):449-53. PubMed ID: 22350222
[TBL] [Abstract][Full Text] [Related]
11. Chondroosseous dysplasia in severe combined immunodeficiency due to adenosine deaminase deficiency (chondroosseous dysplasia in ADA deficiency SCID).
Chakravarti VS; Borns P; Lobell J; Douglas SD
Pediatr Radiol; 1991; 21(6):447-8. PubMed ID: 1749685
[TBL] [Abstract][Full Text] [Related]
12. First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature.
Migliavacca M; Assanelli A; Ponzoni M; Pajno R; Barzaghi F; Giglio F; Ferrua F; Frittoli M; Brigida I; Dionisio F; Nicoletti R; Casiraghi M; Roncarolo MG; Doglioni C; Peccatori J; Ciceri F; Cicalese MP; Aiuti A
Front Immunol; 2018; 9():113. PubMed ID: 29456531
[TBL] [Abstract][Full Text] [Related]
13. Hyperbilirubinemia and rapid fatal hepatic failure in severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA-SCID).
Kühl JS; Schwarz K; Münch A; Schmugge M; Pekrun A; Meisel C; Wahn V; Ebell W; von Bernuth H
Klin Padiatr; 2011 Mar; 223(2):85-9. PubMed ID: 21271505
[TBL] [Abstract][Full Text] [Related]
14. Good Laboratory Practice Preclinical Safety Studies for GSK2696273 (MLV Vector-Based Ex Vivo Gene Therapy for Adenosine Deaminase Deficiency Severe Combined Immunodeficiency) in NSG Mice.
Carriglio N; Klapwijk J; Hernandez RJ; Vezzoli M; Chanut F; Lowe R; Draghici E; Nord M; Albertini P; Cristofori P; Richards J; Staton H; Appleby J; Aiuti A; Sauer AV
Hum Gene Ther Clin Dev; 2017 Mar; 28(1):17-27. PubMed ID: 28319446
[TBL] [Abstract][Full Text] [Related]
15. Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency.
la Marca G; Canessa C; Giocaliere E; Romano F; Duse M; Malvagia S; Lippi F; Funghini S; Bianchi L; Della Bona ML; Valleriani C; Ombrone D; Moriondo M; Villanelli F; Speckmann C; Adams S; Gaspar BH; Hershfield M; Santisteban I; Fairbanks L; Ragusa G; Resti M; de Martino M; Guerrini R; Azzari C
J Allergy Clin Immunol; 2013 Jun; 131(6):1604-10. PubMed ID: 23280131
[TBL] [Abstract][Full Text] [Related]
16. Severe combined immune deficiency in an adenosine deaminase-deficient patient.
Ozdemir O
Allergy Asthma Proc; 2006; 27(2):172-4. PubMed ID: 16724639
[TBL] [Abstract][Full Text] [Related]
17. Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation.
Hsu AP; West RR; Calvo KR; Cuellar-Rodriguez J; Parta M; Kelly SJ; Ganson NJ; Hershfield MS; Holland SM; Hickstein DD
J Allergy Clin Immunol; 2016 Aug; 138(2):628-630.e2. PubMed ID: 27130863
[No Abstract] [Full Text] [Related]
18. [Adenosine deaminase 1 deficiency, an inborn error of metabolism underlying a severe form of combined immunodeficiency].
Giraud A; Lavocat MP; Cremillieux C; Patural H; Thouvenin S; David A; Perignon JL; Stephan JL
Arch Pediatr; 2015 Jun; 22(6):630-5. PubMed ID: 25842197
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.
Otsu M; Yamada M; Nakajima S; Kida M; Maeyama Y; Hatano N; Toita N; Takezaki S; Okura Y; Kobayashi R; Matsumoto Y; Tatsuzawa O; Tsuchida F; Kato S; Kitagawa M; Mineno J; Hershfield MS; Bali P; Candotti F; Onodera M; Kawamura N; Sakiyama Y; Ariga T
J Clin Immunol; 2015 May; 35(4):384-98. PubMed ID: 25875699
[TBL] [Abstract][Full Text] [Related]
20. Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.
Cicalese MP; Ferrua F; Castagnaro L; Pajno R; Barzaghi F; Giannelli S; Dionisio F; Brigida I; Bonopane M; Casiraghi M; Tabucchi A; Carlucci F; Grunebaum E; Adeli M; Bredius RG; Puck JM; Stepensky P; Tezcan I; Rolfe K; De Boever E; Reinhardt RR; Appleby J; Ciceri F; Roncarolo MG; Aiuti A
Blood; 2016 Jul; 128(1):45-54. PubMed ID: 27129325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
